SCHEMBL623172

SCHEMBL623172

NC(=O)c1cocn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL17204496 0.98 ADORA3 (0.39)
Hydrochloric Acid SCHEMBL17204650 0.98
Hydrochloric Acid SCHEMBL17205315 0.98 ADORA3 (0.39)
Trifluoroacetic Acid SCHEMBL29824934 0.87 KMT2A (0.39)
SCHEMBL8865580 0.80 PIK3CD (0.40)
SCHEMBL2170593 0.78
SCHEMBL27788447 0.76
Hydrochloric Acid SCHEMBL28286442 0.76
SCHEMBL2632849 0.76
SCHEMBL27755491 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 491 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250361244-A1 BICYCLIC HETEROCYCLYL DERIVATIVES AS IRAK4 INHIBITORS AURIGENE ONCOLOGY LTD (IN) 2025-11-27 US claimed
EP-3455204-B1 CYCLOPROPYL-AMIDE COMPOUNDS AS DUAL LSD1/HDAC INHIBITORS Jubilant Epicore LLC (US) 2025-10-29 EP claimed
EP-4240351-B1 COMPOSITION FOR ENHANCING INTRA-CELLULAR NITRIC OXIDE GENERATION INST OF LIFE SCIENCES ILS (IN) 2025-08-27 EP claimed
CN-120202200-A Oxo-isoindolinyl substituted tetrahydropyrimidinedione-based compounds and applications thereof 标新生物医药科技(上海)有限公司 2025-06-24 CN claimed
CN-119640248-B Palm-oxidizing additive and IC carrier plate palm-oxidizing method using same 深圳市板明科技股份有限公司 2025-05-20 CN claimed
CN-119640248-A Palm-oxidizing additive and IC carrier plate palm-oxidizing method using same 深圳市板明科技股份有限公司 2025-03-18 CN claimed
US-12178821-B2 Combination therapies for the treatment of cancer CURIS, INC. (US) 2024-12-31 US claimed
EP-3740481-B9 DIHYDROBENZOFURAN AND INDEN ANALOGS AS CARDIAC SARCOMERE INHIBITORS CYTOKINETICS INC (US) 2024-10-23 EP claimed
US-20240294547-A1 BICYCLIC HETEROCYCLYL DERIVATIVES AS IRAK4 INHIBITORS AURIGENE ONCOLOGY LIMITED (IN) 2024-09-05 US claimed
US-20240287052-A1 NOVEL OXAZOLE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ALLERGIC DISEASES COMPRISING THE SAME AZCURIS CO., LTD. (KR) 2024-08-29 US claimed
CN-101522671-A 5- (1(S) -amino-2-hydroxyethyl) -N- [ (2) SCHERING CORP (US) 2009-09-02 CN claimed
WO-2009099736-A2 BENZOXAZOLE CARBOXAMIDE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) LEAD THERAPEUTICS, INC. (US) 2009-08-13 WO claimed
US-20090186905-A1 ANAPLASTIC LYMPHOMA KINASE MODULATORS AND METHODS OF USE EXELIXIS, INC. (US) 2009-07-23 US claimed
CN-101374824-A Heterocyclic GABA-B modulators ASTRAZENECA AB (SE) 2009-02-25 CN claimed
US-20080312291-A1 Heterocyclic Gaba-b Modulators ASTRAZENECA AB (SE) 2008-12-18 US claimed
WO-2008150015-A1 HETEROBICYCLIC COMPOUNDS AS KINASE INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-12-11 WO claimed
EP-1966176-A1 HETEROCYCLIC GABA-B MODULATORS AstraZeneca AB (SE) 2008-09-10 EP claimed
WO-2007073296-A1 HETEROCYCLIC GABA-B MODULATORS ASTRAZENECA AB (SE) 2007-06-28 WO claimed
CN-1207099-A Substituted sulfonamido (thio) carbonyl compounds BAYER AG (DE) 1999-02-03 CN claimed
CN-1143358-A Benzamide analogs, useful as parp (ADP-ribosyltransferase, ADRPT) DNA repair enzyme inhibitors UNIV NEWCASTLE VENTURES LTD (GB) 1997-02-19 CN claimed